Abstract
Analysis of Target Joint Bleeding with Prophylactic Use of Recombinant Factor IX Fc Fusion Protein in Patients with Severe Hemophilia B
Talk to us
Join us for a 30 min session where you can share your feedback and ask us any queries you have